Consumer Genomics Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective                   

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Consumer Genomics Market

5.1. COVID-19 Landscape: Consumer Genomics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Consumer Genomics Market, By Applications

8.1. Consumer Genomics Market, by Applications Type

8.1.1. Genetic Relatedness

8.1.1.1. Market Revenue and Forecast

8.1.2. Diagnostics

8.1.2.1. Market Revenue and Forecast

8.1.3. Lifestyle, Wellness, & Nutrition

8.1.3.1. Market Revenue and Forecast

8.1.4. Ancestry

8.1.4.1. Market Revenue and Forecast

8.1.5. Reproductive Health

8.1.5.1. Market Revenue and Forecast

8.1.6. Personalized Medicine & Pharmacogenetic testing

8.1.6.1. Market Revenue and Forecast

8.1.7. Sports Nutrition & Health

8.1.7.1. Market Revenue and Forecast

8.1.8. Others

8.1.8.1. Market Revenue and Forecast

Chapter 9. Global Consumer Genomics Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Applications

9.1.2. U.S.

9.1.2.1. Market Revenue and Forecast, by Applications

9.1.3. Rest of North America

9.1.3.1. Market Revenue and Forecast, by Applications

9.2. Europe

9.2.1. Market Revenue and Forecast, by Applications

9.2.2. UK

9.2.2.1. Market Revenue and Forecast, by Applications

9.2.3. Germany

9.2.3.1. Market Revenue and Forecast, by Applications

9.2.4. France

9.2.4.1. Market Revenue and Forecast, by Applications

9.2.5. Rest of Europe

9.2.5.1. Market Revenue and Forecast, by Applications

9.3. APAC

9.3.1. Market Revenue and Forecast, by Applications

9.3.2. India

9.3.2.1. Market Revenue and Forecast, by Applications

9.3.3. China

9.3.3.1. Market Revenue and Forecast, by Applications

9.3.4. Japan

9.3.4.1. Market Revenue and Forecast, by Applications

9.3.5. Rest of APAC

9.3.5.1. Market Revenue and Forecast, by Applications

9.4. MEA

9.4.1. Market Revenue and Forecast, by Applications

9.4.2. GCC

9.4.2.1. Market Revenue and Forecast, by Applications

9.4.3. North Africa

9.4.3.1. Market Revenue and Forecast, by Applications

9.4.4. South Africa

9.4.4.1. Market Revenue and Forecast, by Applications

9.4.5. Rest of MEA

9.4.5.1. Market Revenue and Forecast, by Applications

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Applications

9.5.2. Brazil

9.5.2.1. Market Revenue and Forecast, by Applications

9.5.3. Rest of LATAM

9.5.3.1. Market Revenue and Forecast, by Applications

Chapter 10. Company Profiles

10.1. Ancestry

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Gene By Gene, Ltd. (FamilyTree DNA)

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. 23andMe, Inc.

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Color Genomics, Inc.

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Myriad Genetics, Inc.

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Mapmygenome

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Positive Biosciences, Ltd.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Futura Genetics

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Helix OpCo LLC

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. MyHeritage Ltd.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms